Form 4: Recursion Pharmaceuticals CFO Ben R. Taylor Sells Shares to Cover Tax Obligations

Recursion Pharmaceuticals' Chief Financial Officer, Ben R. Taylor, sold shares of Class A Common Stock to cover tax obligations related to the vesting of restricted stock units.

Summary

• Ben R. Taylor, the Chief Financial Officer of Recursion Pharmaceuticals, sold shares of Class A Common Stock on December 16th and 17th, 2024.
• These sales were made to satisfy tax withholding obligations related to the net settlement of restricted stock units.
• On December 16th, 15,668 shares were sold at a price of $6.04 per share.
• On December 17th, 7,057 shares were sold at a price of $6.95 per share.
• Following these transactions, Mr. Taylor beneficially owns 473,867 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Similar stock sales by executives are common across the pharmaceutical and biotech industries, particularly around vesting dates for equity compensation.
• These transactions are typically disclosed via SEC Form 4 filings, which are standard practice for publicly traded companies.
• The sale of shares to cover tax obligations is a normal part of executive compensation and does not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The stock sales may have a minor impact on the stock price, but it is unlikely to be significant given the routine nature of the transaction.

Key Dates

Keywords

Recursion Pharmaceuticals, RXRX, SEC Form 4, Ben R. Taylor, Chief Financial Officer, stock sale, tax obligations, restricted stock units, insider trading